Investigating the effect of natural glucoside product on glycemia of patients with type 2 diabetes, lipidemia and fatty liver disease.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231030059908N4

Enrollment

100

Registered

2024-08-15

Start date

2024-08-15

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Hyperglycemia. Condition 2: Hyperlipidemia. Hyperglycemia, unspecified Hyperlipidemia, unspecified

Interventions

Intervention 1: Intervention group: they will receive the usual medicine along with 500mg glucoside herbal combination six times a day for 3 months under the supervision of a treating physician. Inter

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hyperglycemia Hyperlipidemia

Exclusion criteria

Exclusion criteria: History of allergy to drug compounds

Design outcomes

Primary

Measure	Time frame
Age. Timepoint: Before the intervention. Method of measurement: Age number.;Sex. Timepoint: Before intervention. Method of measurement: Ratio.;BMI. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Numerical formula.;HbA1c. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Blood test.;Fasting blood suger. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Blood test.;Two hours post prandial glucose. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Blood test.;Blood urea. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Blood urea test.;Serum creatinine. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Blood test.;Analyze urine. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Urinalysis.;Cytotoxicity assay. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Blood Test.;Lipid profile. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Lipid profile Blood Test.;Liver function tests. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Blood Test.	—

Measure

Time frame

Age. Timepoint: Before the intervention. Method of measurement: Age number.;Sex. Timepoint: Before intervention. Method of measurement: Ratio.;BMI. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Numerical formula.;HbA1c. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Blood test.;Fasting blood suger. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Blood test.;Two hours post prandial glucose. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Blood test.;Blood urea. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Blood urea test.;Serum creatinine. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Blood test.;Analyze urine. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Urinalysis.;Cytotoxicity assay. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Blood Test.;Lipid profile. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Lipid profile Blood Test.;Liver function tests. Timepoint: Before the start of the intervention and 90 days after the start of the drug. Method of measurement: Blood Test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyed Mohammad Reza Hashemizadeh

Islamic Azad University

Dr.hashemizadeh@gmail.com+98 51 3845 3742

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026